Join
Live feed
·
PRReleasevia Quantisnow
Medtronic plc. logo
Orchestra BioMed Holdings Inc. logo

Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients

ByQuantisnow·Wall Street's wire, on your screen.
MDT· Medtronic plc.OBIO· Orchestra BioMed Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MDT (Medtronic plc.), OBIO (Orchestra BioMed Holdings Inc.) and more on Quantisnow.

Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients | Quantisnow